Search

Author(s): Jyotirmayee Dey[sup.1], Soumya Ranjan Mahapatra[sup.1], T. Kiran Raj[sup.2], Taranjeet Kaur[sup.3], Parul Jain[sup.1], Arushi Tiwari[sup.1], Shubhransu Patro[sup.4], Namrata Misra[sup.1,5] and Mrutyunjay Suar[sup.1,5] Introduction Enterococcus faecium is among the most frequent [...], Enterococcus faecium is an emerging ESKAPE bacterium that is capable of causing severe public health complications in humans. There are currently no licensed treatments or vaccinations to combat the deadly pathogen. We aimed to design a potent and novel prophylactic chimeric vaccine against E. faecium through an immunoinformatics approach The antigenic Penicillin-binding protein 5 (PBP 5) protein was selected to identify B and T cell epitopes, followed by conservancy analysis, population coverage, physiochemical assessment, secondary and tertiary structural analysis. Using various immunoinformatics methods and tools, two linear B-cell epitopes, five CTL epitopes, and two HTL epitopes were finally selected for vaccine development. The constructed vaccine was determined to be highly immunogenic, cytokine-producing, antigenic, non-toxic, non-allergenic, and stable, as well as potentially effective against E. faecium. In addition, disulfide engineering, codon adaptation, and in silico cloning, were used to improve stability and expression efficiency in the host E. coli. Molecular docking and molecular dynamics simulations indicated that the structure of the vaccine is stable and has a high affinity for the TLR4 receptor. The immune simulation results revealed that both B and T cells had an increased response to the vaccination component. Conclusively, the in-depth in silico analysis suggests, the proposed vaccine to elicit a robust immune response against E. faecium infection and hence a promising target for further experimental trials. Keywords: Enterococcus faecium, Penicillin-binding protein, Vaccine, Epitope, Immunoinformatics

Invasive aspergillosis in immunosuppressed patients is difficult to diagnose, is problematic to treat, and results in a high mortality rate (1). Chronic and allergic pulmonary and sinus aspergillosis are increasingly [...]